In studies of non-alcoholic fatty liver disease, RSV was found to decrease the expression of lipogenic genes and triglyceride levels by attenuating NRF2 promoter methylation induced by high-fat diets and high glucose treatments, while also modulating NRF2 signaling pathways [153]. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.